Search Result "Zevalin��"


Research Article

Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 2 Year: 2016 Page: 160-168
Author(s): Parul Thakral,Suhas Singla,Atul Vashist,Madhav P. Yadav,Santosh K. Gupta,Jaya S. Tyagi,Atul Sharma,Chandra S. Bal,Snehlata,Arun Malhotra

Development and biological studies of 177Lu-DOTA-rituximab for the treatment of Non-Hodgkin’s lymphoma

Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 1 Year: 2016 Page: 54-63
Author(s): Adriana V.F. Massicano,Priscilla B. Pujatti,Lais F. Alcarde,Miriam F. Suzuki,Patrick J. Spencer,Elaine B. Araújo

Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art

Journal: Current Drug Targets
Volume: 17 Issue: 9 Year: 2016 Page: 1072-1082
Author(s): Magdalena Witkowska, Piotr Smolewski

Prospects of Bacteriotherapy with Nanotechnology in Nanoparticledrug Conjugation Approach for Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 23 Issue: 14 Year: 2016 Page: 1477-1494
Author(s): Ritu Raj,Surajit Das

Review Article

New Molecular Targets of Anticancer Therapy – Current Status and Perspectives

Journal: Current Medicinal Chemistry
Volume: 23 Issue: 37 Year: 2016 Page: 4176-4220
Author(s): Marianna Zajac,Izabela Muszalska,Anna Jelinska

Review Article open access plus

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

Journal: Clinical Cancer Drugs
Volume: 3 Issue: 2 Year: 2016 Page: 76-86
Author(s): Xiao-Yan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier, Harald Dinter

Results 1 - 1 of 6

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy